Stock listing

NASDAQ:NRIX Nurix Therapeutics, Inc. Stock

Home listing (NASDAQ) of Nurix Therapeutics, Inc.

Follow Nurix Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:NRIX

$24.42 USD -0.53 (-2.1%)

Close on Oct 16, 2026

Since Jul 6, 2026 +1.6% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$24.27 – $25.36 USDOct 16, 2026
Volume
3.69M sharesOct 16, 2026
Market value
$2.67B USDAt the close on Oct 16, 2026 · price × 109.2M shares outstanding
Nurix Therapeutics, Inc. logo
Ticker
NASDAQ:NRIX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Oct 12, 2026

Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia

Oct 6, 2026

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

Oct 5, 2026

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

Sep 29, 2026

Nurix Therapeutics to Participate in Upcoming September Investor Conferences

Sep 1, 2026

Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer

Aug 20, 2026

Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader

Aug 4, 2026

Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Aug 4, 2026

Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Jul 21, 2026

Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Jul 9, 2026

All Nurix Therapeutics, Inc. news

Decks

Nurix Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
32 in the last 12 months · 178 in all · newest Oct 12, 2026 · oldest 2020
Decks
29 decks · latest Jun 8, 2026

Where Nurix Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:NRIX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:NRIXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Nurix Therapeutics, Inc.